Sudipta Tripathi to Humans
This is a "connection" page, showing publications Sudipta Tripathi has written about Humans.
Connection Strength
0.170
-
Tripathi S, Julé AM, Zhuo Z, Schreiber BL, Martin-Moreno PL, Sui SH, Waaga-Gasser AM, Chandraker A. Single-cell and multi-omic characterization of ex vivo expanded ASTRLs from stable kidney transplant recipients reveals a regulatory T cell phenotype. Sci Rep. 2026 Jan 14; 16(1):3619.
Score: 0.035
-
Tripathi S, Martin-Moreno PL, Kavalam G, Schreiber BL, Waaga-Gasser AM, Chandraker A. Adenosinergic Pathway and Linked Suppression: Two Critical Suppressive Mechanisms of Human Donor Antigen Specific Regulatory T Cell Lines Expanded Post Transplant. Front Immunol. 2022; 13:849939.
Score: 0.027
-
Tripathi S, Guleria I. Biomarkers in Fetomaternal Tolerance. Clin Lab Med. 2019 03; 39(1):145-156.
Score: 0.021
-
Tripathi S, Guleria I. Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus. Biomed J. 2015 Jan-Feb; 38(1):25-31.
Score: 0.016
-
Ben Saad A, Arghiani N, Weilheimer AD, Gentile SD, Toles BJ, Tripathi S, Mohsin Sayed S, Chandraker A, Mullen AC. Prime editing models the MTARC1 A165T variant in human liver organoids, demonstrating reduced steatosis, inflammation, and fibrosis. Hepatol Commun. 2026 Oct 01; 10(10).
Score: 0.009
-
Ribas-Filho JM, N Doelken E, Tripathi S, Polat B, Lissner R, Böeldicke T, Ribas CAPM, Malafaia O, Gasser M, Waaga-Gasser AM. ALDH1 and ALCAM as emerging biomarkers in personalized rectal cancer therapy. Arq Bras Cir Dig. 2026; 38:e1920.
Score: 0.009
-
Ribas CAPM, N Doelken E, Tripathi S, Polat B, Lissner R, Böeldicke T, Ribas-Filho JM, Malafaia O, Gasser M, Waaga-Gasser AM. Prognostic and predictive value of AXL and C-MET in patients with rectal cancer. Arq Bras Cir Dig. 2026; 38:e1918.
Score: 0.009
-
Schreiber B, Tripathi S, Nikiforow S, Chandraker A. Adoptive Immune Effector Cell Therapies in Cancer and Solid Organ Transplantation: A Review. Semin Nephrol. 2024 01; 44(1):151498.
Score: 0.008
-
Jadhav S, Tripathi S, Chandrekar A, Waikar SS, Hsiao LL. A novel antibody for the detection of alternatively spliced secreted KLOTHO isoform in human plasma. PLoS One. 2021; 16(1):e0245614.
Score: 0.006
-
Starling RC, Armstrong B, Bridges ND, Eisen H, Givertz MM, Kfoury AG, Kobashigawa J, Ikle D, Morrison Y, Pinney S, Stehlik J, Tripathi S, Sayegh MH, Chandraker A. Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation. J Am Coll Cardiol. 2019 07 09; 74(1):36-51.
Score: 0.006
-
Stehlik J, Armstrong B, Baran DA, Bridges ND, Chandraker A, Gordon R, De Marco T, Givertz MM, Heroux A, Iklé D, Hunt J, Kfoury AG, Madsen JC, Morrison Y, Feller E, Pinney S, Tripathi S, Heeger PS, Starling RC. Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18. Am J Transplant. 2019 05; 19(5):1518-1528.
Score: 0.005
-
Martin-Moreno PL, Tripathi S, Chandraker A. Regulatory T Cells and Kidney Transplantation. Clin J Am Soc Nephrol. 2018 11 07; 13(11):1760-1764.
Score: 0.005
-
Grimmig T, Moench R, Kreckel J, Haack S, Rueckert F, Rehder R, Tripathi S, Ribas C, Chandraker A, Germer CT, Gasser M, Waaga-Gasser AM. Toll Like Receptor 2, 4, and 9 Signaling Promotes Autoregulative Tumor Cell Growth and VEGF/PDGF Expression in Human Pancreatic Cancer. Int J Mol Sci. 2016 Dec 08; 17(12).
Score: 0.005
-
Moench R, Grimmig T, Kannen V, Tripathi S, Faber M, Moll EM, Chandraker A, Lissner R, Germer CT, Waaga-Gasser AM, Gasser M. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer. Oncotarget. 2016 Oct 18; 7(42):68749-68767.
Score: 0.005
-
Grimmig T, Matthes N, Hoeland K, Tripathi S, Chandraker A, Grimm M, Moench R, Moll EM, Friess H, Tsaur I, Blaheta RA, Germer CT, Waaga-Gasser AM, Gasser M. TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer. Int J Oncol. 2015 Sep; 47(3):857-66.
Score: 0.004